GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE309nnn/GSE309864/primaryOK200GenomicsMus musculusGenome binding/occupancy profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309864GEOGSEfalseModulating MyoD1 dosage activates alternate cell fate beyond myogenic differentiation [ATAC-seq]The study investigates how MyoD1 dosage controls myogenic cell fate, employing bulk RNA-seq, ATAC-seq, and CUT&RUN. We determined genome-wide transcriptional, chromatin accessibility, and MyoD1 binding profiles in C2C12 myoblasts expressing endogenous Halo-tagged MyoD1 or doxycycline-inducible Halo–MyoD1, under growth and differentiation conditions with low or high MyoD1 dosage.2026/06/03GSE309864GSM9283709GSM9283708GSM9283707GSM9283706GSM9283701GSM9283700GSM9283710GSM9283699GSM9283698GSM9283705GSM9283704GSM9283703GSM9283702GSM9283697GSM9283696GSM928369524247309864Mus musculus